Navigation Links
Moderate doses of radiation therapy to unaffected breast may prevent second breast cancers
Date:1/23/2014

treat the other breast with a moderate dose of radiation and kill any premalignant cells that could lead to second cancers?" said Dr. Brenner.

The critical question was whether treating the breast with a moderate dose of radiation would indeed lower the overall risk of a second cancer. "We know that there will be a balance between radiation killing premalignant cells and radiation producing premalignant cells, but it seemed that using the right radiation dose would put the balance strongly toward lowering the cancer risk," Dr. Brenner said.

The current study tested this hypothesis by performing PMI on transgenic mice that have a high risk of developing breast cancer, simulating the unaffected breast of a breast cancer survivor. Lead shields were positioned so that one side of each mouse was shielded from the radiation. As predicted, a moderate dose of radiation reduced the breast cancer risk in the treated side by a factor of about 3.

The researchers are now planning to test PMI in a clinical trial.

If PMI proves to be successful in patients, it could be used as an adjunct to tamoxifen or aromatase inhibitors for women with estrogen receptor-positive tumors and as a standalone therapy for those with estrogen-receptor negative tumors, who do not benefit from drug therapy. In either case, PMI could be performed concurrently with radiotherapy of the affected breast.

PMI could have a substantial clinical impact. At present, there are more than 2.6 million breast cancer survivors in the U.S., according to the American Cancer Society. "About 160,000 of these women are likely to develop cancer in their other breast," said Dr. Brenner. "If PMI does, in fact, reduce the incidence of cancer by three-fold, as suggested by our results, about 100,000 cases of breast cancer could be prevented."

"Whether PMI would work for women with BRACA1 or BRACA2 mutations, which greatly increase one's risk for breast and/or ovarian canc
'/>"/>

Contact: Karin Eskenazi
ket2116@columbia.edu
212-342-0508
Columbia University Medical Center
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Study: Moderate alcohol consumption boosts bodys immune system
2. New study suggests coral reefs may be able to adapt to moderate climate change
3. Moderate exercise not only treats, but prevents depression
4. Latest research suggests moderate coffee consumption is not associated with increased CVD risk
5. Moderate exercising encourages a healthier lifestyle
6. UEA research shows moderate exercise could be good for your tendons
7. Experts find epigenetic changes moderate reality distortion in schizophrenia patients
8. Cells must use their brakes moderately for effective speed control
9. CNBC Senior Analyst Ron Insana Moderates Discussion On Biotech Seeds At The Food Dialogues(SM): Chicago
10. Researchers issue forecast for moderate New England red tide in 2013
11. Moderate drinking decreases number of new brain cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Moderate doses of radiation therapy to unaffected breast may prevent second breast cancers
(Date:2/18/2015)... Feb. 18, 2015  Cepheid (NASDAQ: CPHD ) ... following conferences, and invited investors to participate via webcast. ... MA Tuesday, March 3, 2015 at 11.20 a.m. ... Orlando, FL Wednesday, March 4, 2015 at ... access the live webcasts for these events, please visit Cepheid,s ...
(Date:2/11/2015)... According to a ... Product (Cards and Readers, Biometrics, Controllers, Management Software), ... Healthcare, Education) and By Geography - Global Forecast and Analysis to ... Control Market is expected to reach $10.4 ... of 10.6% between 2014 and 2020. ...
(Date:2/5/2015)... RESEARCH TRIANGLE PARK, N.C. , Feb. 5, 2015 ... as a specialist logistics company and has launched a ... industry,s only Clinical Logistics Organization (CLO).  The new campaign ... with emphasis on patient, protocol and shipments. ... Patient First , aligns Marken,s priorities with its ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... has benefited an,important field of biomedical research, scientists ... of Cryptococcus neoformans, a,fungus whose importance as a ... worldwide epidemic and the increased use of,immunosuppressive therapies.,The ... revealed,differences in the virulence strategies used by C. ...
... and beyond are characterized by extensive segments that ... genes that are closed to gene transcription. Scientists ... is the vital need for genomic stability, for ... other disruptions of the genome's integrity. , Genomic ...
... For the first time, a group of scientists has ... all of the ecosystems on Earth, and the outlook ... 2001, the Millennium Ecosystem Assessment program will issue its ... London, Washington, D.C., Tokyo, Beijing, New Delhi, Brasilia, Cairo, ...
Cached Biology News:Scientists decipher genome of fungus that can cause life-threatening infections 2Scientists decipher genome of fungus that can cause life-threatening infections 3Scientists decipher genome of fungus that can cause life-threatening infections 4Enzyme shown to help protect genomic stability 2Scientists collaborate to assess health of global environment 2Scientists collaborate to assess health of global environment 3
(Date:3/3/2015)... Genedata, a leading provider of advanced ... research, today announced that Pfizer Inc. has licensed ... at Pfizer biopharma research and development sites in ... global deployment and roll out project at Pfizer’s ... (CTI), and Pharmaceutical Sciences groups. , “Pfizer ...
(Date:3/3/2015)... 2015 Research and Markets ( ... PharmaBiotech,s new report "Personalized Medicine - Scientific ... , The aim of personalized medicine ... drug to the right patient and, in some ... a patient according to his/her genotype. This report ...
(Date:3/3/2015)... , Mar. 03, 2015 Research and ... the addition of Jain PharmaBiotech,s new report ... to their offering. , Gene ... vectors, nonviral vectors and cell therapy with genetically ... of drug delivery and various routes of administration ...
(Date:3/3/2015)... 2015 Elsevier,s DirectCourse online ... competency-based training to comply with new CMS requirements ... a new crosswalk tool to help providers ... for direct service workers as a means to comply ... regulations. CMS amended the regulations, effective March ...
Breaking Biology Technology:Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 3Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 2Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 3
... responders contained the recent E. coli outbreak quickly, but ... automated system used to identify the disease and coordinate ... information technology played a key role in alerting public ... play an even greater role in future public health ...
... of ethanol from alfalfa or switchgrass isn't nearly as efficient ... grass crops for fuel won't pay, says Paul Weimer. , ... out of biomass from crops such as switchgrass, Weimer is ... large heap of fermentation residue from the ethanol-making process - ...
... Nell Merlino and Laurie Benson may be as different as, ... enriching vision for women entrepreneurs, including those operating in the ... as the eye can see, but the result may be ... want to take their business to the next level. Specifically, ...
Cached Biology Technology:Technology played key role in E. coli alerts 2Technology played key role in E. coli alerts 3Technology played key role in E. coli alerts 4Glue made from ethanol leftovers might be worth more than fuel 2Glue made from ethanol leftovers might be worth more than fuel 3Women entrepreneurs reach for $1M level 2Women entrepreneurs reach for $1M level 3
Rat Antibody to Mouse TCR VB8.1,8.2:FITC Recognises the V beta 8.1 and V beta 8.2 determinants of the murine T cell receptor. Specificity: mouse TCR VB8.1 and 8.2...
fli-1...
Vesicle Associated Membrane Protein (VAMP 1/2)...
Anti-Mouse Valpha 2 TCR, Purified (Clone B20.1) (rat IgG2a)...
Biology Products: